» Articles » PMID: 35844498

Diabetes Mellitus Promotes the Development of Atherosclerosis: The Role of NLRP3

Overview
Journal Front Immunol
Date 2022 Jul 18
PMID 35844498
Authors
Affiliations
Soon will be listed here.
Abstract

Atherosclerosis is one of the main complications of diabetes mellitus, involving a variety of pathogenic factors. Endothelial dysfunction, inflammation, and oxidative stress are hallmarks of diabetes mellitus and atherosclerosis. Although the ability of diabetes to promote atherosclerosis has been demonstrated, a deeper understanding of the underlying biological mechanisms is critical to identifying new targets. NLRP3 plays an important role in both diabetes and atherosclerosis. While the diversity of its activation modes is one of the underlying causes of complex effects in the progression of diabetes and atherosclerosis, it also provides many new insights for targeted interventions in metabolic diseases.

Citing Articles

Role of Peripheral NLRP3 Inflammasome in Cognitive Impairments: Insights of Non-central Factors.

Qiao M, Ni J, Qing H, Qiu Y, Quan Z Mol Neurobiol. 2025; .

PMID: 40000575 DOI: 10.1007/s12035-025-04779-8.


Exosomal NEDD4L derived from HG+oxLDL-induced vascular endothelial cells accelerates macrophage M1 polarization and oxLDL uptake by ubiquitinating IκBα and PPARγ.

Chen G, Pei Y, Jiang P, Ye Q, Xie Z, Gyawali L Cell Biol Toxicol. 2025; 41(1):23.

PMID: 39775116 PMC: 11706887. DOI: 10.1007/s10565-024-09973-3.


Association between atherosclerosis and the development of multi-organ pathologies.

Dabravolski S, Churov A, Elizova N, Ravani A, Karimova A, Sukhorukov V SAGE Open Med. 2024; 12:20503121241310013.

PMID: 39734765 PMC: 11672402. DOI: 10.1177/20503121241310013.


[Gly14]-Humanin ameliorates high glucose-induced endothelial senescence via SIRT6.

Li M, Liu Z, Cao X, Xiao W, Wang S, Zhao C Sci Rep. 2024; 14(1):30924.

PMID: 39730568 PMC: 11681169. DOI: 10.1038/s41598-024-81878-x.


Hemoglobin A1c and abdominal obesity as predictors of diabetes and ASCVD in individuals with prediabetes in UK Biobank: a prospective observational study.

Pencina K, Thanassoulis G, Pencina M, Toth P, Sniderman A Cardiovasc Diabetol. 2024; 23(1):448.

PMID: 39702291 PMC: 11660550. DOI: 10.1186/s12933-024-02525-3.


References
1.
Death A, Fisher E, McGrath K, Yue D . High glucose alters matrix metalloproteinase expression in two key vascular cells: potential impact on atherosclerosis in diabetes. Atherosclerosis. 2003; 168(2):263-9. DOI: 10.1016/s0021-9150(03)00140-0. View

2.
Herder C, Dalmas E, Boni-Schnetzler M, Donath M . The IL-1 Pathway in Type 2 Diabetes and Cardiovascular Complications. Trends Endocrinol Metab. 2015; 26(10):551-563. DOI: 10.1016/j.tem.2015.08.001. View

3.
Westerterp M, Fotakis P, Ouimet M, Bochem A, Zhang H, Molusky M . Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis. Circulation. 2018; 138(9):898-912. PMC: 6160368. DOI: 10.1161/CIRCULATIONAHA.117.032636. View

4.
Rheinheimer J, de Souza B, Cardoso N, Bauer A, Crispim D . Current role of the NLRP3 inflammasome on obesity and insulin resistance: A systematic review. Metabolism. 2017; 74:1-9. DOI: 10.1016/j.metabol.2017.06.002. View

5.
Krakauer T . Inflammasome, mTORC1 activation, and metabolic derangement contribute to the susceptibility of diabetics to infections. Med Hypotheses. 2015; 85(6):997-1001. DOI: 10.1016/j.mehy.2015.08.019. View